Title |
Molecular Pathogenesis and Targeted Therapy of Pancreatic Cancer
|
---|---|
Published in |
Annals of Surgical Oncology, March 2015
|
DOI | 10.1245/s10434-015-4463-x |
Pubmed ID | |
Authors |
Shinji Tanaka |
Abstract |
Accumulation of multiple genetic and/or epigenetic abnormalities is required for generation and progression of cancers, and the survival of cancer cells might depend on addiction to these abnormalities. Because disruption of such dependency on the abnormal molecules should cause the cancer cell death, so-called oncogene addiction is the rationale for molecular targeted therapy. Pancreatic cancer, especially pancreatic ductal adenocarcinoma, is one of the most lethal malignancies in humans, and remains a challenging problem in targeted therapy compared to other malignancies such as pancreatic neuroendocrine tumor. This review summarizes the molecular pathogenesis of pancreatic cancer on the basis of the recent studies of driver mutations including chromatin remodeling factors, and promising concepts "cancer stemness" and "stromal niche" for the strategy of novel targeted therapy. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 29% |
France | 1 | 14% |
Netherlands | 1 | 14% |
Unknown | 3 | 43% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 57% |
Practitioners (doctors, other healthcare professionals) | 1 | 14% |
Scientists | 1 | 14% |
Science communicators (journalists, bloggers, editors) | 1 | 14% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 56 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 9 | 16% |
Student > Bachelor | 9 | 16% |
Student > Ph. D. Student | 7 | 13% |
Other | 4 | 7% |
Student > Doctoral Student | 3 | 5% |
Other | 10 | 18% |
Unknown | 14 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 17 | 30% |
Biochemistry, Genetics and Molecular Biology | 7 | 13% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 9% |
Agricultural and Biological Sciences | 4 | 7% |
Engineering | 2 | 4% |
Other | 5 | 9% |
Unknown | 16 | 29% |